Clinical and Biological Features of Favorable-Risk Acute Myelogenous Leukemia – Is Favorable-Risk AML Really Favorable?

Leukemia - United Kingdom
doi 10.1038/sj.leu.2403659
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Is Hyperdiploidy a Favorable Cytogenetics in Adults With B‐lymphoblastic Leukemia?

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Lung Resistance-Related Protein (LRP) Predicts Favorable Therapeutic Outcome in Acute Myeloid Leukemia

Scientific Reports
Multidisciplinary
2019English

High Expression of miR-25 Predicts Favorable Chemotherapy Outcome in Patients With Acute Myeloid Leukemia

Cancer Cell International
Cancer ResearchOncologyGenetics
2019English

Is Antipsychotic Drug-Induced Weight Gain Associated With a Favorable Clinical Response?

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2000English

Favorable Outcome of Improperly Diagnosed Myocarditis

Fundamental and Clinical Medicine
2017English

Biocompatibility of Titanium^|^mdash;favorable Properties

Keikinzoku/Journal of Japan Institute of Light Metals
Mechanics of MaterialsAlloysMaterials ChemistryMetalsMechanical Engineering
2012English

Management of Patients With Cytogenetically Normal Acute Myeloid Leukemia Who Have Neither Favorable Nor Unfavorable Markers

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2014English

Favorable Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Acute Promyelocytic Leukemia in Childhood

Bone Marrow Transplantation
TransplantationHematology
2004English

PSCA Expression Is Associated With Favorable Tumor Features and Reduced PSA Recurrence in Operated Prostate Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy